School of Biological Sciences, University of Manchester, Manchester M13 9PT, United Kingdom
![]() |
Abstract |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Adherent epithelial cells require interactions
with the extracellular matrix for their survival, though
the mechanism is ill-defined. In long term cultures of
primary mammary epithelial cells, a laminin-rich basement membrane (BM) but not collagen I suppresses
apoptosis, indicating that adhesion survival signals are
specific in their response (Pullan et al. 1996. J. Cell Sci.
109:631-642). We now demonstrate that the signal from
BM is mediated by integrins and requires both the
6
and
1 subunits. In addition, a hormonal signal from insulin or insulin-like growth factors, but not hydrocortisone or prolactin, is necessary to suppress mammary
cell apoptosis, indicating that BM and soluble factors
cooperate in survival signaling. Insulin induced autophosphorylation of its receptor whether mammary cells
were cultured on collagen I or BM substrata. However,
both the tyrosine phosphorylation of insulin receptor
substrate-1 and its association with phosphatidylinositol 3-kinase were enhanced in cells cultured on BM, as
was the phosphorylation of the phosphatidylinositol 3-kinase effector, protein kinase B. These results suggest a novel extracellular matrix-dependent restriction
point in insulin signaling in mammary epithelial cells.
The proximal signal transduction event of insulin receptor phosphorylation is not dependent on extracellular
matrix, but the activation of downstream effectors requires adhesion to BM. Since phosphatidylinositol
3-kinase was required for mammary epithelial cell survival, we propose that a possible mechanism for BM-mediated suppression of apoptosis is through its facilitative effects on insulin signaling.
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
CELLS in multicellular organisms monitor their environment through interactions with neighboring cells and through receptors for both soluble and locally acting factors including extracellular matrix (ECM)1. In addition to providing signals for proliferation, differentiation, and migration, such interactions are also essential for survival and in their absence, cells undergo apoptosis. While the cellular signaling pathways that control the decision to enter apoptosis are currently being studied extensively, little is known about the interplay between survival factors derived from the soluble milieu and the ECM.
The mammary gland is a particularly useful system to
study mechanisms that regulate apoptosis. Most of its epithelial cells are removed by apoptosis during involution of
the gland after lactation, and the survival of purified mammary epithelial cells can be manipulated in primary culture (Strange et al., 1992; Pullan et al., 1996
). Several models have recently emerged to explain the post-lactational
induction of apoptosis. One possibility is that cessation of
suckling results in hormonal changes in the nursing mother
that alter the supply of soluble cell survival factors. As an
example of this, withdrawal of soluble survival factors such
as insulin or insulin-like growth factor I (IGF-I) from cultured cells results in apoptosis (Rodriguez-Tarduchy et al.,
1992
; Harrington et al., 1994
; Parrizas et al., 1997
). In the
mammary gland in vivo, the expression of an IGF-binding
protein which inhibits IGF action, IGFBP-5, is dramatically increased after weaning and may therefore act to trigger apoptosis (Tonner et al., 1997
). Alternatively, expression of matrix-degrading metalloproteinases after weaning
may trigger cell death by breaking down cell-ECM interactions (Talhouk et al., 1992
; Alexander et al., 1996
; Lund et
al., 1996
). Although these hypotheses offer plausible explanations for the induction of apoptosis in vivo, none
have been proven, suggesting that the mechanism may be
more easily deciphered using a cell culture model. However, even in cell cultures, very little is currently known
about the control of mammary epithelial apoptosis.
Epithelial cells undergo apoptosis if they are denied
contact with ECM (Frisch and Francis, 1994; Khwaja et al.,
1997
) and indeed, ECM is a survival factor in a number of
cell types (Frisch and Ruoslahti, 1997
). The ECM is linked
to the cytoskeleton and to cytoplasmic signaling pathways
through integrins, and both integrins and some of their
downstream effectors, including p125FAK, are involved in
the survival response (Frisch et al., 1996
). However, there
are very few natural situations where simple epithelial cells are denied contact with the ECM for appreciable
periods of time, and we have therefore developed a
more physiological model than previously used to examine ECM survival signaling. Primary cultures of mouse
mammary epithelial cells and mammary cell lines show a
differential long term apoptotic response to different
ECM in tissue culture (Boudreau et al., 1995
; Pullan et al.,
1996
). On collagen I-coated substrata these cells form organized cobblestone monolayers, express E-cadherin and
desmocollins at their cell-cell junctions, and are polarized
(Streuli, 1995
; Runswick et al., 1996
). However, when cultured on specialized ECM known as basement membrane
(BM), which contains laminin, collagen IV, nidogen and
perlecan, they develop into three-dimensional structures
which mimic alveoli in vivo (Aggeler et al., 1991
). Although in both situations they interact with the respective substrata through integrins, cells cultured on collagen I
show extensive apoptosis over periods of several days
whereas those in contact with BM do not (Pullan et al.,
1996
). Since mammary cells interact with collagen and BM
through different integrin receptors, it is likely that only
certain integrins deliver a survival signal (Howlett et al.,
1995
; Metcalfe and Streuli, 1997
).
Recent models for integrin-mediated control of phenotype in adherent cells have indicated that integrins might
cooperate with soluble factors to drive signaling pathways,
possibly through the formation of multi-protein adhesion
complexes (Miyamoto et al., 1996; Schneller et al., 1997
).
Indeed, both proliferation and differentiation (Streuli et al.,
1995
; Zhu et al., 1996
) are dependent on ECM as well as
growth and differentiation factors. For example, cell anchorage regulates the activation of mitogen activated protein kinase by serum or EGF, and epithelial cell interactions with BM are necessary for prolactin to trigger the kinase Jak2 and activate the transcription factor Stat5 (Lin
et al., 1997
; Renshaw et al., 1997
; Edwards et al., 1998
).
In this paper we have sought to determine whether soluble factors and BM act coordinately to regulate the suppression of apoptosis in primary cultures of mammary epithelium. We show that insulin is an essential survival ligand but that the cell-ECM interactions that lead to survival are necessary for insulin to trigger its downstream survival signaling pathway.
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cell Culture
Primary mammary epithelial cells were prepared from 14.5-18.5-d pregnant ICR mice as previously described (Pullan et al., 1996). After culture
for 3 days, cells were trypsinized, passed through a 70-µm nylon mesh
(Falcon) to remove large cell aggregates, and plated at 1 × 105 cells/cm2 in
DMEM/F12 medium containing 5% fetal calf serum (Advanced Protein Products) and 5 ng/ml epidermal growth factor (Harlan Sera-Lab) overnight, then washed and cultured in serum-free DMEM/F12 medium containing appropriate combinations of 2.8 nM hydrocortisone, 880 nM insulin, 150 nM prolactin (Sigma), with or without inhibitors of the insulin
signaling pathway. Some experiments included IGF-I or IGF-II (R&D
systems) in place of insulin.
The ECM substrata used for these studies were rat tail collagen I and
reconstituted BM matrix prepared from Engelbreth-Holm-Swarm (EHS)
tumor (Pullan and Streuli, 1996). Collagen I was coated onto tissue culture
plates overnight at 80 µg/ml and washed extensively before use, or in
some experiments commercially precoated Biocoat dishes were used
(Becton Dickinson). A factor-reduced preparation of the BM matrix was
prepared using sequential ammonium sulfate precipitations (Taub et al.,
1990
) and coated onto tissue culture plastic at 14 mg/ml. In some experiments, factor-reduced BM matrix was diluted into the culture medium (final concentration 100 or 400 µg/ml) and overlaid onto first passage cells
plated on collagen I (Streuli et al., 1995
).
Apoptosis Assays
To analyze DNA integrity, first passage cells were cultured in medium containing appropriate hormones and inhibitors for two days, then washed
over a period of 2 h to remove the accumulated dead cells and debris. Fresh
medium was added to cells and after 4 h newly apoptotic cells were collected from the medium and pooled with any remaining attached cells. DNA
was extracted from samples (Pullan et al., 1996), its OD was measured at
260 nm, and separated on a 1% agarose gel to confirm DNA loading after
staining the gel with ethidium bromide. Equal amounts of DNA were separated by conventional agarose gel electrophoresis, southern blotted, and
apoptotic DNA ladders were visualized by hybridization with a digoxigenin-labeled total mouse genomic DNA probe (Boehringer Mannheim).
Single cell cultures were prepared by straining first passage cells
through a 20-µm mesh, pelleting and resuspending in factor-reduced BM
matrix at 2-4 × 106 cells/ml, as described (Streuli et al., 1991). 100 µl of
the mammary cell suspension was gelled for 60 min on dishes precoated with a thin layer of BM, then cultured in serum-free DMEM/F12 medium
containing appropriate hormones, inhibitors or antibodies for 2 d before
fixation in 2% paraformaldehyde. 25-µm cryosections were stained with
0.5 µg/ml Hoechst 33258 and apoptotic nuclei were counted in the single
cell population. Each experiment was repeated two to three times and in
each experimental condition, >600 single cells were scored for apoptosis.
Polyclonal rabbit anti-
1 integrin antibody was prepared in this laboratory (Edwards and Streuli, 1998
). It was shown to inhibit the adhesion of
first passage mouse mammary epithelial cells to laminin, collagen IV, but
not fibronectin or vitronectin. Purified rat monoclonal antibody to
6 integrin (GoH3) and its rat IgG2a isotype control were obtained from Serotec. Rabbit polyclonal anti-laminin antibody was raised against purified
laminin isolated from EHS tumor (a kind gift of P. Yurchenco, Robert
Wood Johnson Medical School, Piscataway, NJ). This laminin had previously been shown to contain laminin A and B chains but not collagen IV
or nidogen (Streuli et al., 1995
). A protein A-derived IgG fraction from
the rabbit serum was subsequently purified on an EHS affinity column.
This antibody significantly inhibited the adhesion of first passage mouse
mammary epithelial cells to laminin at 5 µg/ml and completely inhibited adhesion at 30 µg/ml (data not shown).
A quantitative assay for apoptosis based on measuring cellular detachment from different substrata was previously described (Pullan et al.,
1996). Cells detaching into the medium of first passage cultures over periods of 4 h were pelleted and counted using either a hemocytometer or a
Coulter counter. Detached cells were confirmed to have apoptotic morphology by fluorescence microscopy after staining with 0.5 µg/ml Hoechst
33258, and the remaining monolayers were also stained with Hoechst
33258 to confirm that apoptotic cells did not accumulate there. Quantitative data for detachment assays are all relative to the number of cells that attached to each substrata after plating.
Protein Analysis
Mammary cells were cultured for 2 d, then washed and serum-free
DMEM/F12 medium with or without insulin was replaced for 15 min. The
cells were washed twice with 1 mM Na3VO4, 10 mM NaF in PBS and
scraped into NET lysis buffer (50 mM Tris-Cl, 150 mM NaCl, 1% NP-40,
2 mM EDTA, 10 mM NaF, 1 mM Na3VO4, 10 µg/ml aprotinin, 20 µM
leupeptin, 1 mM PMSF, pH 7.5). Cells were lysed by vortexing and then
rotating for 30-60 min at 4°C, and detergent insoluble proteins were
cleared by centrifugation at 7,000 g. Aliquots of samples were subjected to
SDS-PAGE on 6% gels, and the gels were stained with Coomassie Brilliant Blue to normalize protein levels. Equal amounts of protein were immunoprecipitated either with anti-IRS-1 antibody (UBI) or anti-insulin
receptor antibody (Transduction Laboratories) and 20 µl protein
A-Sepharose beads (Zymed Laboratories), before being separated on 6%
gels under reducing conditions and transferred to Immobilon-P membranes (Millipore). Phosphotyrosine blots were blocked in 1% BSA in
TBST, (50 mM Tris-Cl, 150 mM NaCl, 0.1% Tween 20, pH 7.5) and incubated overnight with monoclonal antibody 4G10 (UBI) at 1:1,000 for
insulin receptor
or 1:3,000 for IRS-1. Interaction of the p85 subunit of PI
3-kinase with IRS-1 was examined by probing IRS-1 immunoblots with
anti-PI 3-kinase (UBI). For each experiment, equal amounts of protein
were confirmed for IRS-1 by blocking IRS-1 immunoblots in 3% nonfat
dry milk/PBS and probing with 1:3,000 anti-IRS-1 antibody; for insulin receptor
, whole cell lysate blots were blocked with 3% BSA/TBST and
probed with 1:250 anti-insulin receptor
. Protein kinase B (PKB, otherwise known as c-Akt) was analyzed by immunoblotting equal amounts of cell protein with either an anti-PKB antibody or an antibody specific for
phosphorylated PKB (both at 1:2,000; New England Biolabs). Proteins
were visualized by enhanced chemiluminescence (Amersham).
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Survival of Mammary Epithelium Is Regulated Coordinately by Insulin and BM
Mammary epithelial cells require appropriate cell-ECM
interactions for survival since they undergo apoptosis in
the absence of a BM (Pullan et al., 1996). To determine
the mechanism by which BM suppresses apoptosis, we
asked whether BM was able to act as a survival ligand by
itself or whether additional factors were required to prevent cell death. First passage mammary epithelial cells isolated from midpregnant mice were plated on substrata of
collagen I or a reconstituted BM matrix derived from the
EHS tumor. Culture on a BM matrix in the presence of
lactogenic hormones, insulin, prolactin, and hydrocortisone, suppressed apoptosis, whereas cells died on collagen
I (Fig. 1 A). However, removal of lactogenic hormones
from the medium resulted in apoptotic death of the cells,
even those cultured on the BM matrix (Fig. 1 A). This indicated that survival of mammary cells required two signals, one from the BM and a second signal from the hormonal milieu.
|
To determine which of the three hormones acted in a
survival capacity, cells plated on BM were incubated with
combinations of insulin, prolactin, and hydrocortisone and
the extent of cell death was measured by DNA fragmentation. Apoptosis occurred only when the cells were cultured
without insulin (Fig. 1 B). We also used an alternate assay
for apoptosis, where single mammary cells were cultured
within a BM gel, but apart from each other so that they
were unable to form cell-cell interactions (Streuli et al., 1991). In this assay, apoptosis was measured by determining nuclear morphology after culture for 48 h (Fig. 1 C).
20-30% of single cells were apoptotic providing insulin
was present in the medium. However, in the absence of insulin, cell death increased significantly (P < 0.01) to 60-
70% (Fig. 1 D). These two different approaches collectively demonstrate that BM does not act alone to suppress apoptosis in primary cultures of mammary epithelia. Instead, it regulates survival in combination with signals elicited by insulin. Furthermore, the data show survival is not
dependent on mammary differentiation, since removal of
prolactin and hydrocortisone, which are required for milk
protein gene expression, did not result in apoptosis.
In addition to the ability of insulin to interact with its
own receptor, this hormone can also bind to the IGF receptor although with a 100-1,000-fold lower affinity (Parrizas et al., 1997). IGF-I or IGF-II have been shown to
act as survival factors in other cell types (Rodriguez-Tarduchy et al., 1992
; Harrington et al., 1994
; Kulik et al.,
1997
), and we therefore tested whether they could directly
suppress mammary apoptosis. At physiological concentrations, both IGF-I and IGF-II significantly inhibited the
DNA fragmentation exhibited by cells cultured on a BM
matrix in the absence of other hormones (Fig. 1 E). Moreover, IGF-I suppressed apoptosis (P < 0.01) in single
mammary cells cultured within the BM gel to the same extent as insulin (Fig. 1 F). The survival of mammary epithelia can therefore be regulated by signals from IGF-I and
IGF-II in addition to those from insulin, and these signals
act coordinately with BM.
Laminin Is a Survival Ligand for Mammary Epithelial Cells
Mammary epithelial cells plated onto a BM substratum
form multicellular, alveolar-like structures (Barcellos-Hoff
et al., 1989; Aggeler et al., 1991
). Thus, it was important to
ask whether this complex three-dimensional structure was
involved with mammary cell survival, or if signals from the
BM-integrin interactions were sufficient. Therefore, we
cultured mammary cells as monolayers on collagen I and
incubated them with the EHS BM preparation diluted into
the culture medium. Under these conditions, the cells did not form alveoli but remained as monolayers on the culture dish with some matrix proteins precipitating over the
cells (Streuli et al., 1995
). Dilution of the BM preparation
140-fold to 0.1 mg/ml resulted in significant suppression of
apoptosis, both in a quantitative assay (Fig. 2 A) and in
DNA fragmentation studies (Fig. 2 B). BM proteins diluted 35-fold to 0.4 mg/ml suppressed apoptosis to virtually the same extent as in the cells cultured as alveoli on
top of a BM substratum (Fig. 2, A and B). Thus, the three-dimensional multicellular structure is not a primary determinant of mammary cell survival.
|
BM contains several ECM proteins and one component,
laminin, has previously been shown to be a survival ligand
for other cell types (Kim et al., 1994; Vachon et al., 1996
;
Bozzo et al., 1997
). To determine whether laminin was a
survival factor for mammary epithelial cells we developed
a function-blocking anti-laminin antibody that inhibited
adhesion of mammary cells to laminin (data not shown).
We assessed whether this antibody was able to interfere with the survival of mammary cells that had been cultured
as single cells within BM gels (Fig. 3 A). We found that
when the anti-laminin antibody was included in the gel,
mammary cells underwent apoptosis even when they were
cultured in the presence of insulin. In contrast, an adhesion-blocking antibody directed against fibronectin had no
effect (Fig. 3 A), neither did the inclusion of an RGD peptide in the assay (Fig. 3 B). These results demonstrated
that within the context of a three-dimensional BM gel,
laminin has a survival-promoting function. Indeed, they
show that both insulin and laminin can act as survival
ligands for mammary epithelial cells, although they do not
rule out the possibility that other soluble factors or ECM
proteins may have a similar function.
|
BM Regulates Mammary Survival through 6 and
1
Integrin Subunit
Major cellular receptors for BM proteins, including laminin,
are the transmembrane heterodimeric integrin receptors.
To confirm that BM acts directly to suppress apoptosis,
and that the survival signals were mediated by integrins,
we assessed whether function-blocking anti-integrin antibodies interfered with the mammary cell survival using the
single cell assay. In experiments where an adhesion-blocking polyclonal anti-mouse 1 integrin antibody was included in the gel, insulin failed to suppress apoptosis. Indeed, the levels of death were similar to those observed
in single mammary cells in the absence of insulin (Fig. 4 A).
One receptor for laminin is
6
1 integrin, and we therefore performed parallel experiments using a function-blocking anti-
6 integrin antibody (Fig. 4 B). The cellular
response was similar to that for the anti-
1 integrin antibody, providing evidence that both the
6 and
1 integrin subunits can transduce survival signals in normal mammary epithelial cells. Suitable antibodies to other mouse
integrin subunits were not available to test for specificity.
Therefore, we performed similar experiments using function-blocking anti-human integrin antibodies and demonstrated that
6 and
1 integrin, but not
2 integrin, acts as
survival receptors in primary cultures of human mammary
cells (Oliver, J., M. O'Hare, and C.H. Streuli, manuscript in preparation). In addition, our results with anti-fibronectin antibodies and RGD peptides do not support a role for
v integrins in mammary cell survival.
|
Our combined data using function-blocking antibodies
to laminin and to integrin subunits show that suppression
of apoptosis in mammary epithelia depends on interactions of the cells with BM through the 6 and/or
1 integrin receptors, and that laminin can act as a survival ligand.
BM and Insulin Regulate Survival in Mammary Cells by Cross Talk of Signaling Pathways
Since both insulin and laminin had been identified as
mammary cell survival factors, it is possible that they trigger separate pathways required for suppressing apoptosis.
However, recent work on the control of cell cycle and
differentiation indicates that ECM affects the ability of
growth factors/cytokines to trigger their downstream signaling kinases (Lin et al., 1997; Renshaw et al., 1997
; Edwards et al., 1998
). Thus an alternative mechanism to
explain survival signaling in mammary cells is that the insulin- and BM-triggered pathways converge. To determine
whether this was indeed the case, the extent of tyrosine
phosphorylation in the proximal components of the insulin
signaling pathway was measured (Fig. 5).
|
Insulin interacts with its receptor, causing receptor oligomerization and activation of the kinase domain. This results in tyrosine phosphorylation of the receptor subunit.
The adaptor protein insulin receptor substrate-1 (IRS-1) is
recruited to the insulin receptor, then becomes tyrosine
phosphorylated creating SH2 domain interaction sites for
downstream enzymes such as PI 3-kinase (Myers et al.,
1994
; Sun et al., 1992
). The ability of insulin to signal in
primary cultures of mammary cells plated on BM was
compared with those on collagen I. Tyrosine phosphorylation of the insulin receptor
subunit occurred within 15 min of insulin treatment and was independent of cell-
ECM interactions (Fig. 5 A). However, the ability of IRS-1
to become tyrosine phosphorylated in response to insulin
was strongly dependent on cell interactions with BM, and
virtually no IRS-1 phosphorylation was observed in cells
cultured on collagen I (Fig. 5 B).
It has been shown in several cell types that PI 3-kinase is
required for preventing apoptosis, and that in neuronal
cells and fibroblasts IGF-I suppresses apoptosis through
PI 3-kinase (Yao and Cooper, 1995; Minshall et al., 1996
;
Dudek et al., 1997
; Kennedy et al., 1997
; Kulik et al., 1997
;
Miller et al., 1997
; Parrizas et al., 1997
). PI 3-kinase is activated in response to insulin or IGF-I following the interaction of its p85 subunit with IRS-1, and therefore we assessed
whether cell-ECM interactions regulated the association
of the p85 subunit of PI 3-kinase with IRS-1 (Myers et al.,
1994
). PI 3-kinase did not associate with IRS-1 in mammary cells cultured on either substratum in the absence of
insulin (Fig. 5 C). However, within 15 min of insulin treatment PI 3-kinase bound IRS-1, but the extent of the interaction was strongly dependent on cell adhesion to BM;
quantitation of the data indicated that threefold more PI
3-kinase bound to IRS-1 in cells cultured on a BM substratum than in cells cultured on collagen I (Fig. 5 D).
One downstream target of PI 3-kinase signaling pathway is PKB, which has previously been implicated in the
suppression of apoptosis (Dudek et al., 1997; Kauffmann-Zeh et al., 1997
; Kulik et al., 1997
; Crowder and Freeman,
1998
). This enzyme is recruited to the plasma membrane
following PI 3-kinase phosphorylation of membrane lipids,
and then activated phosphorylation on serine/threonine residues (Downward, 1998
). Using an antibody specific for
phosphorylated PKB, we found that maximal activation
only occurred when mammary cells treated with insulin
had been cultured on BM (Fig. 6). Wortmannin completely abrogated insulin-induced PKB phosphorylation.
Since many of the assays to measure mammary apoptosis
in our work were carried out over several days, we also
measured PKB phosphorylation status in cells cultured
with insulin for 3 days. PKB was only phosphorylated in
cells cultured on BM, even though its level remained constant whether the cells were on collagen I or BM substrata. These results are an indirect confirmation that PI 3-kinase
activity depends on coordinate signals from insulin and
BM. Most importantly, they demonstrate that the PKB
pathway, already shown to be a critical determinant of survival in other cell systems, relies on converging insulin and
ECM signals in mammary epithelia.
|
Thus, the ECM dependence of insulin signaling correlates with the ability of BM, but not collagen I, to deliver survival cues.
Pharmacological Inhibitors of Enzymes in the PI 3-Kinase Signaling Pathway Induce Apoptosis of Mammary Epithelial Cells
The experiments described above suggested that the mechanism through which cell-ECM interactions regulate apoptotic fate in mammary epithelial cells is through a control on insulin-mediated PI 3-kinase signaling. To determine whether the PI 3-kinase pathway, or related pathways, were required for survival, the effects of the pharmacological inhibitors LY 294002 and wortmannin were examined in two independent assays for mammary apoptosis.
Mammary cells were cultured on a BM matrix with 10-
100 nM IGF-I, with or without 0.1 or 1 µM LY 294002. In
the absence of soluble factors the cells underwent apoptosis (Fig. 7 A, lane 2), and this was suppressed by IGF-I
(Fig. 7 A, lanes 3-6). However, IGF-I failed to suppress
apoptosis when LY 294002 was included in the cultures
(Fig. 7 A, lanes 7-10). We observed low levels of apoptosis
at 0.1 µM and very extensive DNA fragmentation at 1 µM
LY 294002, a concentration previously shown to inhibit
IGF-I signaling and PI 3-kinase activity (Vlahos et al.,
1994; Parrizas et al., 1997
). Similar results were obtained
with wortmannin (data not shown).
|
The effect of the kinase inhibitors on suppression of
apoptosis by insulin was also examined in the single cell
assay. As before, mammary cells cultured within BM matrix were not able to survive in the absence of insulin. Insulin rescued the cells from apoptosis, but low levels of wortmannin (1 µM) and LY 294002 (0.1 µM) blocked survival
signaling (Fig. 7 B). The target specificity for wortmannin
is fairly broad but includes PI 3-kinase whereas LY 294002 is specific for PI 3-kinase (Vlahos et al., 1994; Ui et al.,
1995
). Thus, these two experiments indicate that the PI 3-kinase class of enzymes are necessary for mammary cell survival.
Together our results suggest that mammary epithelial cell survival depends upon a functional PI 3-kinase signaling pathway which is normally triggered by insulin when the cells are cultured with a BM substratum. Restricting the activity of this pathway by culture on collagen I results in cell death.
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The mechanisms that regulate death and survival decisions in epithelial cells are not understood. Yet these are fundamental cellular processes and are essential not only for deciphering the control of normal development, but also for designing strategies to tackle progressive diseases such as breast cancer.
In this study, we have addressed the mechanism whereby
BM suppresses apoptosis in primary cultures of mammary
epithelial cells and found that this type of ECM controls
the ability of insulin to deliver survival signals. We have
demonstrated that insulin is necessary to prevent death of
mammary cells through the PI 3-kinase pathway, and furthermore that insulin-mediated interaction of PI 3-kinase
with IRS-1 and phosphorylation of PKB, a key enzyme downstream in the PI 3-kinase pathway, is influenced by
cell interactions with BM. This provides new evidence for
the importance of ECM in the growth factor-mediated
regulation of cell phenotype. Since 6 and
1 integrins are
necessary for mammary cell survival, our work supports
the notion that one function of integrins is to regulate
growth factor signaling.
Two Signals Are Required for Survival of Mammary Epithelial Cells
Our previous studies, and those of others, have demonstrated that mammary epithelial cells depend on BM for
survival (Boudreau et al., 1995; Pullan et al., 1996
). We
have now found that they require a further signal from soluble ligands to remain alive. Of three hormones tested, insulin, but not hydrocortisone or prolactin, was found to be
necessary for suppression of apoptosis (Fig. 1). This survival effect of insulin could be mimicked by IGFs.
Insulin and IGFs have been shown to rescue apoptosis
in several cell lines following interleukin-3 or serum withdrawal (Rodriguez-Tarduchy et al., 1992; Harrington et al.,
1994
; Parrizas et al., 1997
). However, although IGFs have
been proposed to act as survival factors in mammary
gland, this has not been demonstrated directly. For example, overexpression of des(1-3)hIGF-I or IGF-I in mammary glands of transgenic mice delayed involution and the
glands showed lower levels of apoptosis, but the target
cells were not identified (Hadsell et al., 1996
; Neuenschwander et al., 1996
). In the experiments performed in
our study, purified populations of mouse mammary epithelial cells survived in the presence of insulin or IGFs, indicating that the factors suppress apoptosis by a direct action on the epithelial cells themselves.
Glucocorticoids have also been demonstrated to rescue
cells from apoptosis in the mammary gland, although it
was not determined whether the hormone acts directly on
epithelial cells or through an indirect mechanism (Feng et al.,
1995; Lund et al., 1996
). In purified mammary epithelial
cells hydrocortisone had a minimal effect on survival, and
therefore its function in vivo would appear indirect. Thus,
although in vivo studies have indicated a role for both
IGFs and glucocorticoids in suppressing apoptosis in mammary gland, our study with isolated cells shows that
only IGFs act directly on the epithelial cells themselves.
IGFs are normally only synthesized by stromal cells in the
mammary gland, but their expression is regulated by a synergy between growth hormone and estradiol (Yee et al.,
1989
; Ruan et al., 1995
). Therefore, one explanation for
the inhibition of apoptosis by hydrocortisone in vivo is
that this steroid can act on stromal cells to alter IGF expression. Alternatively, since IGFBP-5 has been suggested to induce mammary involution, glucocorticoids may inhibit apoptosis in vivo by decreasing IGFBP-5 synthesis,
as occurs in cultured fibroblasts (Conover et al., 1995
;
Tonner et al., 1997
).
The ability of prolactin to suppress apoptosis directly
in purified mammary epithelial cells was also tested. In
agreement with previous studies which showed that prolactin could not rescue mammary apoptosis in vivo, we
demonstrated that it also had a negligible effect on epithelial cell survival in culture (Feng et al., 1995; Marti et al.,
1997
). Prolactin regulates intracellular signaling through a
Jak/Stat pathway, which is required for mammary differentiation. Although other cytokines have been proposed
to suppress apoptosis through Stat transcription factors, it
appears that this pathway is not directly involved in mammary cell survival (Fujio et al., 1997
).
Together our data show that, of the hormones tested, insulin is sufficient for the survival of mammary cells cultured on BM. Since prolactin and hydrocortisone, in addition to insulin, are necessary for lactation, the results indicate that mammary cell survival does not depend on differentiation. Moreover, as cells on collagen I undergo apoptosis even in the presence of all three hormones, the survival mechanism would appear to have more to do with cell-ECM interactions than with differentiation.
Laminin Is a Survival Ligand for Mammary Cells
Cell-ECM interactions are known to suppress apoptosis in
epithelial cells (Meredith et al., 1993; Frisch and Francis,
1994
; Khwaja et al., 1997
). However, such studies are
based on comparing the survival potential of suspension-cultured epithelial cell lines with those adhering to ECM
in short term assays. We have developed a model where
primary mammary cells isolated directly from tissue are
maintained on physiological substrata in longer term assays. These cells have not been selected for their ability to
form cell lines and therefore retain an apoptotic potential that is as close as possible to that in vivo. They undergo
apoptosis specifically after culture for several days on tissue culture plastic or collagen I, but not on BM (Pullan et
al., 1996
). The cells plated on a BM substratum form multicellular structures resembling alveoli in vivo (Barcellos-Hoff et al., 1989
; Aggeler et al., 1991
). However, this
three-dimensional architecture did not appear to play a
role in suppression of apoptosis (Fig. 2). Under conditions
where the cells remained as monolayers, apoptosis was efficiently suppressed by diluted BM proteins precipitating over the cells.
Further verification that BM had a direct survival signaling role came from studies using function-blocking antibodies. Using a single cell assay developed previously for
analysis of differentiation (Streuli et al., 1991), we found
that although insulin was able to significantly suppress
apoptosis in cells cultured within a three-dimensional BM
gel, it was not able to do so if anti-laminin antibodies were
included (Fig. 3). Laminin has previously been shown to
act as a survival ligand for other cell lineages including fibrosarcoma and neuroblastoma cells and has been implicated in preventing apoptosis during myogenesis (Kim et al.,
1994
; Vachon et al., 1996
; Bozzo et al., 1997
; Vachon et al.,
1997
). Our results extend these previous findings and show
that laminin also has a survival function in mammary epithelium. However, laminin may not be a survival ligand
for all cells, since endothelial cells underwent apoptosis on
laminin substrata but not on fibronectin or vitronectin
(Wary et al., 1996
). Thus, distinct cell types have a different requirement for ECM to rescue them from apoptosis. It remains to be determined whether or not the survival
response to different ECM ligands is mediated through
similar signaling pathways.
Integrins Are Survival Receptors in Mammary Cells
In several cell systems, integrins have been shown to be required for mediating a survival response (Frisch and Ruoslahti, 1997). We tested the possibility that integrins delivered survival signals in mammary cells by examining the
survival of single cells in BM gels after treatment with
function-blocking antibodies, and found that both
6 and
1 integrins were necessary to prevent the cells from
undergoing apoptosis. Although
1 integrins have been
shown to be required for mammary epithelial cell survival, our results augment these studies by providing the first direct evidence that
6 integrin functions in such a pathway
(Boudreau et al., 1995
; Howlett et al., 1995
; Fig. 4). These
findings have recently been confirmed in our experiments
with primary human breast epithelia, where anti-
6 and
anti-
1 integrin antibodies induced cell death, although
antibodies to the
2 subunit did not. The latter result indicates a specificity of response as mammary cells express
significant levels of
2 integrin, but it also suggests that the
2
1 integrin, a receptor for collagen, is not involved with
suppressing mammary apoptosis.
The 1 and
3 integrin subunits have previously been
shown to be survival receptors (Brooks et al., 1994
; Boudreau et al., 1995
; Howlett et al., 1995
; Zhang et al., 1995
;
Scatena et al., 1998
). RGD is a peptide substrate for
v
3
integrin but we found that it had no effects on mammary
cell survival. Furthermore, in preliminary immunostaining
experiments with anti-
v integrin antibodies, we have
only detected this subunit in the epithelial cells of virgin
mammary gland and it appeared to be completely absent
from pregnant and lactating tissue. Therefore, our data would not support the possibility that it is a survival receptor for mammary cells isolated from pregnant mammary
gland, even though it does have this role in endothelia
(Brooks et al., 1994
; Scatena et al., 1998
). In addition to
the
1 integrin subunit, mammary cells also express
4
integrin, and both of these can partner the
6 subunit.
Therefore, our data are not yet sufficient to confirm that
laminin suppresses apoptosis through a direct cell interaction with the
6
1 integrin heterodimer, neither do they exclude the possibility that other integrin subunits are involved in survival. However, they do demonstrate that
laminin is a ligand for survival and that the
6 and
1 subunits can act as survival receptors.
The metastatic breast cancer cell line, MDA-MB-435
expresses 6
1 integrin. Tumors induced by a derivative
cell line in which
6
1 was functionally ablated were much
smaller those of the parental cells, and showed a sixfold
higher apoptotic/mitotic index (Wewer et al., 1997
). These
results suggest that
6 integrin provides an anti-apoptotic
signal in vivo as well as in culture and together with the
present study, they may explain why higher levels of
6 integrin in human breast carcinomas correlate with an increased likelihood of patient morbidity (Friedrichs et al.,
1995
). Moreover, they suggest that
6 integrin-ligand interactions might represent a target for therapeutic intervention in breast disease, especially in combination with
agents which inhibit growth factor-mediated survival signals.
Receptor Cross Talk and the Control of Apoptosis
Since both BM and insulin were required for sustained
prevention of apoptosis in mammary cells, it was possible
that these ligands triggered either parallel or convergent
survival pathways. An abundance of studies indicate that
PI 3-kinase is essential for suppressing apoptosis in other
cell systems, possibly through PKB which has been implicated as a downstream regulator of survival (Yao and
Cooper, 1995; Minshall et al., 1996
; Dudek et al., 1997
; Kauffmann-Zeh et al., 1997
; Kennedy et al., 1997
; Khwaja
et al., 1997
; Kulik et al., 1997
; Parrizas et al., 1997
; Crowder and Freeman, 1998
). Our experiments using inhibitors also demonstrated a requirement for PI 3-kinase in
mammary cell survival (Fig. 7). Therefore, we examined
whether this pathway was independently regulated by the
two separate ligands or if BM controlled the ability of insulin to trigger its phosphorylation cascade, by measuring
the levels of phosphotyrosine in its proximal signaling proteins.
Insulin rapidly induced tyrosine phosphorylation of its
receptor. However, the signaling events downstream of
the insulin receptor resulting in IRS-1 tyrosine phosphorylation and its association with PI 3-kinase were only propagated in cells cultured on BM and not on collagen I (Fig.
5). These results contrast with a study using CHO cells
overexpressing insulin receptor, which showed that transient adhesion to fibronectin >20 min enhanced the insulin-induced phosphorylation of both the receptor and IRS-1
(Guilherme et al., 1998). Our data support the conclusion
that ECM amplifies insulin signaling, but extends it by
showing that once nontransfected primary epithelial cells
have become established within an ECM environment
over several days, they develop a selective sensitivity to
growth factor signaling. Thus, the cellular environment determines whether the insulin signal can be propagated efficiently, and this only occurs when the cells contact a BM
but not when they are on collagen I. Indeed, the results indicate the existence of an ECM-dependent restriction
point in insulin signaling, which occurs downstream of insulin receptor phosphorylation.
The conclusion that BM and insulin cooperate to drive
insulin signaling was confirmed in further experiments
where we examined PKB phosphorylation, using both
short and long term treatments with insulin (Fig. 6). Cell-
matrix interactions had a similar effect of enhancing EGF
signaling in MDCK cells, although in that study the PKB
activation was examined in cells briefly attached to an
ECM in comparison with those detached from a substratum (Khwaja et al., 1997). Together, these complementary
results indicate that both the short and long term activation of enzymes in the PI 3-kinase signaling pathway requires adherent cells to be in the correct ECM microenvironment, which contributes to both EGF and insulin signaling.
At the current time we do not know whether PKB is absolutely required for mammary cell survival, but given the
results from other cell systems, this seems likely. Candidates for the downstream link between PKB and the apoptotic machinery include glycogen synthase kinase-3, procaspase-9, and the pro-apoptotic protein Bad (Datta et al.,
1997; del Peso et al., 1997
; Cardone et al., 1998
; Pap and
Cooper, 1998
). Although the phosphorylation of PKB and
Bad have been dissociated from each other, primary cultures of mammary epithelial cells do express Bad, which
therefore remains a potential target for regulation by PKB
(Scheid and Duronio, 1998
; our unpublished data).
Adhesion to ECM has previously been shown to suppress apoptosis in several cell types (Meredith et al., 1993;
Frisch and Francis, 1994
; Kim et al., 1994
; Vachon et al.,
1996
; Wary et al., 1996
; Bozzo et al., 1997
; Khwaja et al.,
1997
). In addition, cell-ECM interactions trigger integrin-mediated downstream phosphorylation cascades involving
MAP kinase and PI 3-kinase, providing possible mechanisms for ECM control of survival (Khwaja et al., 1997
;
King et al., 1997
; Lin et al., 1997
). However, in the mammary gland model we have now demonstrated that although integrin signaling is necessary for survival, sustained cell interactions with a BM substratum alone are
not sufficient to suppress apoptosis. In addition, insulin or
IGFs are also required. Similar conclusions have been
reached in studies of the cell cycle where serum factors and ECM are both required for MAP kinase activation,
cyclin E-cdk2 activation, and retinoblastoma phosphorylation (Zhu et al., 1996
; Renshaw et al., 1997
). Dual signals
from soluble factors and ECM are also implicated in the
control of mammary differentiation, where prolactin and
BM are both necessary for triggering the prolactin signaling cassette, Stat5 DNA binding, and milk protein gene
transcription (Streuli et al., 1995
; Edwards et al., 1998
).
Although our work shows that both laminin and insulin act as survival ligands for mammary cells, we cannot rule out the possibility that other types of ligand are important in regulating survival. Insulin, for example, was only able to suppress apoptosis of single mammary cells cultured within BM by about twofold, suggesting that other factors may play a role in mammary cell survival in vivo. Preliminary studies with primary cultures of human mammary epithelial cells, have demonstrated that apoptosis in the single cell assay can be reduced by insulin, but is further suppressed by EGF. But with mouse mammary cells, EGF does not have an additional survival effect over and above insulin (Oliver, J., and C.H. Streuli, unpublished data). Therefore, it may be that additional cytokines can suppress apoptosis still further than insulin and BM in the mouse system. Even if other mammary survival factors remain to be identified, our data are still sufficient to demonstrate that both insulin and integrin contribute to the survival of mammary cells.
In summary, these studies indicate that an important
function of cell-ECM interactions is to modulate growth
factor and cytokine responses. This suggests that current
thinking about growth factor signaling in adherent cells
should include a component from the ECM. One mechanism might be via direct or indirect associations between
integrin and growth factor receptors, as has been demonstrated for v
3 integrin and the insulin and PDGF receptors, or with integrin and downstream components in the
insulin signaling pathway, as shown with
v
3 integrin and
IRS-1 (Vuori and Ruoslahti, 1994
; Schneller et al., 1997
).
The role of integrins and the cytoskeleton in signal transduction may be to provide a scaffold whereby components of growth factors cassettes are assembled into discreet domains within the cell, so that they can propagate signals efficiently. Indeed, a modular nature for membrane signaling complexes has been proposed, which may explain the
recruitment of signaling proteins to cytoskeletal structures
such as adhesion plaques (Miyamoto et al., 1995
; Plopper
et al., 1995
; Pawson and Scott, 1997
; Simons and Ikonen,
1997
). Our current goal is to address this issue by determining whether the macromolecular organization of insulin signaling proteins and integrins in mammary cells cultured on BM are different to those in cells on collagen I.
![]() |
Footnotes |
---|
Address correspondence to Charles Streuli, School of Biological Sciences, University of Manchester, 3.239 Stopford Building, Oxford Road, Manchester M13 9PT, UK. Tel.: 44 161 275 5626. Fax: 44 161 275 7700. E-mail: charles.streuli{at}man.ac.uk
Received for publication 13 March 1998 and in revised form 10 February 1999.
C.H. Streuli is a Wellcome Senior Fellow in Basic Biomedical Science.
C. Dive is a Lister Fellow.
The authors are grateful in particular to Dr. Andrew Gilmore and also to Drs. Neil Anderson, Gwynneth Edwards, David Garrod, Teresa Klinowska, and John Hickman for critical review of the manuscript.
![]() |
Abbreviations used in this paper |
---|
BM, basement membrane; ECM, extracellular matrix; EHS, Engelbreth-Holm-Swarm tumor; IGF, insulin-like growth factor; IRS, insulin receptor substrate; PI 3-kinase, phosphatidylinositol 3-kinase; PKB, protein kinase B.
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1. | Aggeler, J., J. Ward, L.M. Blackie, M.H. Barcellos-Hoff, C.H. Streuli, and M.J. Bissell. 1991. Cytodifferentiation of mouse mammary epithelial cells cultured on a reconstituted basement membrane reveals striking similarities to development in vivo. J. Cell Sci. 99: 407-417 [Abstract]. |
2. | Alexander, C.M., E.W. Howard, M.J. Bissell, and Z. Werb. 1996. Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene. J. Cell Biol. 135: 1669-1677 [Abstract]. |
3. | Barcellos-Hoff, M.H., J. Aggeler, T.G. Ram, and M.J. Bissell. 1989. Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development 105: 223-235 [Abstract]. |
4. | Boudreau, N., C.J. Sympson, Z. Werb, and M.J. Bissell. 1995. Suppression of ice and apoptosis in mammary epithelial cells by extracellular matrix. Science. 267: 891-893 |
5. | Bozzo, C., G. Bellomo, L. Silengo, G. Tarone, and F. Altruda. 1997. Soluble integrin ligands and growth factors independently rescue neuroblastoma cells from apoptosis under nonadherent conditions. Exp. Cell Res. 237: 326-337 |
6. | Brooks, P.C., A.M.P. Montgomery, M. Rosenfeld, R.A. Reisfeld, T.H. Hu, G. Klier, and D.A. Cheresh. 1994. Integrin alpha(v)beta(3) antagonists promote tumor-regression by inducing apoptosis of angiogenic blood vessels. Cell. 79: 1157-1164 |
7. |
Cardone, M.H.,
N. Roy,
H.R. Stennicke,
G.S. Salvesen,
T.F. Franke,
E. Stanbridge,
S. Frisch, and
J.C. Reed.
1998.
Regulation of cell death protease
caspase-9 by phosphorylation.
Science.
282:
1318-1321
|
8. | Conover, C.A., J.T. Clarkson, and L.K. Bale. 1995. Effect of glucocorticoid on insulin-like growth factor (IGF) regulation of IGF-binding protein expression in fibroblasts. Endocrinology. 136: 1403-1410 [Abstract]. |
9. |
Crowder, R.J., and
R.S. Freeman.
1998.
Phosphatidylinositol 3-kinase and Akt
protein kinase are necessary and sufficient for the survival of nerve growth
factor-dependent sympathetic neurons.
J. Neurosci.
18:
2933-2943
|
10. | Datta, S.R., H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh, and M.E. Greenberg. 1997. Akt phosphorylation of BAD couples survival signals to the cell- intrinsic death machinery. Cell. 91: 231-241 |
11. |
del Peso, L.,
M. Gonzalez-Garcia,
C. Page,
R. Herrera, and
G. Nunez.
1997.
Interleukin-3-induced phosphorylation of BAD through the protein kinase
Akt.
Science.
278:
687-689
|
12. | Downward, J.. 1998. Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell Biol. 10: 262-267 |
13. |
Dudek, H.,
S.R. Datta,
T.F. Franke,
M.J. Birnbaum,
R. Yao,
G.M. Cooper,
R.A. Segal,
D.R. Kaplan, and
M.E. Greenberg.
1997.
Regulation of neuronal
survival by the serine-threonine protein kinase Akt.
Science.
275:
661-665
|
14. | Edwards, G.M., and C.H. Streuli. 1998. Preparing a polyclonal antibody to
mouse ![]() |
15. |
Edwards, G.M.,
F.H. Wilford,
X.W. Liu,
L. Hennighausen,
J. Djiane, and
C.H. Streuli.
1998.
Regulation of mammary differentiation by extracellular matrix
involves protein-tyrosine phosphatases.
J. Biol. Chem.
273:
9495-9500
|
16. | Feng, Z.W., A. Marti, B. Jehn, H.J. Altermatt, G. Chicaiza, and R. Jaggi. 1995. Glucocorticoid and progesterone inhibit involution and programmed cell-death in the mouse mammary gland. J. Cell Biol. 131: 1095-1103 [Abstract]. |
17. | Friedrichs, K., P. Ruiz, F. Franke, I. Gille, H.J. Terpe, and B.A. Imhof. 1995. High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res. 55: 901-906 [Abstract]. |
18. | Frisch, S.M., and H. Francis. 1994. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124: 619-626 [Abstract]. |
19. | Frisch, S.M., and E. Ruoslahti. 1997. Integrins and anoikis. Curr. Opin. Cell Biol. 9: 701-706 |
20. | Frisch, S.M., K. Vuori, E. Ruoslahti, and P.Y. Chanhui. 1996. Control of adhesion-dependent cell-survival by focal adhesion kinase. J. Cell Biol. 134: 793-799 [Abstract]. |
21. |
Fujio, Y.,
K. Kunisada,
H. Hirota,
K. Yamuchi-Takihara, and
T. Kishimoto.
1997.
Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes.
J. Clin. Invest.
99:
2898-2905
|
22. |
Guilherme, A.,
K. Torres, and
M.P. Czech.
1998.
Cross-talk between insulin receptor and integrin alpha5 beta1 signaling pathways.
J. Biol. Chem.
273:
22899-22903
|
23. | Hadsell, D.L., N.M. Greenberg, J.M. Fligger, C.R. Baumrucker, and J.M. Rosen. 1996. Targeted expression of des(1-3) human insulin-like growth-factor-I in transgenic mice influences mammary-gland development and Igf-binding protein expression. Endocrinology. 137: 321-330 [Abstract]. |
24. | Harrington, E.A., M.R. Bennett, A. Fanidi, and G.I. Evan. 1994. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO (Eur. Mol. Biol. Organ.) J. 13: 3286-3295 [Abstract]. |
25. |
Howlett, A.R.,
N. Bailey,
C. Damsky,
O.W. Petersen, and
M.J. Bissell.
1995.
Cellular growth and survival are mediated by beta-1 integrins in normal human breast epithelium but not in breast carcinoma.
J. Cell Sci.
108:
1945-1957
|
26. | Kauffmann-Zeh, A., P. Rodriguez, Viciana, E. Ulrich, C. Gilbert, P. Coffer, J. Downward, and G. Evan. 1997. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature. 385: 544-548 |
27. | Kennedy, S.G., A.J. Wagner, S.D. Conzen, J. Jordan, A. Bellacosa, P.N. Tsichlis, and N. Hay. 1997. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 11: 701-713 [Abstract]. |
28. |
Khwaja, A.,
P. Rodriguez,
Viciana,
S. Wennstrom,
P.H. Warne, and
J. Downward.
1997.
Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway.
EMBO (Eur. Mol. Biol. Organ.) J.
16:
2783-2793
|
29. | Kim, W.H., H.W. Schnaper, M. Nomizu, Y. Yamada, and H.K. Kleinman. 1994. Apoptosis in human fibrosarcoma cells is induced by a multimeric synthetic Tyr-Ile-Gly-Ser-Arg (YIGSR)-containing polypeptide from laminin. Cancer Res. 54: 5005-5010 [Abstract]. |
30. | King, W.G., M.D. Mattaliano, T.O. Chan, P.N. Tsichlis, and J.S. Brugge. 1997. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation. Mol. Cell. Biol. 17: 4406-4418 [Abstract]. |
31. | Kulik, G., A. Klippel, and M.J. Weber. 1997. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol. 17: 1595-1606 [Abstract]. |
32. |
Lin, T.H.,
A.E. Aplin,
Y. Shen,
Q.M. Chen,
M. Schaller,
L. Romer,
I. Aukhil, and
R.L. Juliano.
1997.
Integrin-mediated activation of MAP kinase is independent of FAK: evidence for dual integrin signaling pathways in fibroblasts.
J. Cell Biol.
136:
1385-1395
|
33. |
Lin, T.H.,
Q.M. Chen,
A. Howe, and
R.L. Juliano.
1997.
Cell anchorage permits efficient signal transduction between Ras and its downstream kinases.
J.
Biol. Chem.
272:
8849-8852
|
34. |
Lund, L.R.,
J. Romer,
N. Thomasset,
H. Solberg,
C. Pyke,
M.J. Bissell,
K. Dano, and
Z. Werb.
1996.
Two distinct phases of apoptosis in mammary-gland involution![]() |
35. | Marti, A., Z. Feng, H.J. Altermatt, and R. Jaggi. 1997. Milk accumulation triggers apoptosis of mammary epithelial cells. Eur. J. Cell Biol. 73: 158-165 |
36. | Meredith, J.E., B. Fazeli, and M.A. Schwartz. 1993. The extracellular matrix as a cell survival factor. Mol. Biol. Cell. 4: 953-961 [Abstract]. |
37. | Metcalfe, A., and C. Streuli. 1997. Epithelial apoptosis. Bioessays 19: 711-720 |
38. |
Miller, T.M.,
M.G. Tansey,
E.M. Johnson Jr., and
D.J. Creedon.
1997.
Inhibition of phosphatidylinositol 3-kinase activity blocks depolarization- and insulin-like growth factor I-mediated survival of cerebellar granule cells.
J.
Biol. Chem.
272:
9847-9853
|
39. | Minshall, C., S. Arkins, G.G. Freund, and K.W. Kelley. 1996. Requirement for phosphatidylinositol 3'-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor. J. Immunol. 156: 939-947 [Abstract]. |
40. |
Miyamoto, S.,
H. Teramoto,
O.A. Coso,
J.S. Gutkind,
P.D. Burbelo,
S.K. Akiyama, and
K.M. Yamada.
1995.
Integrin function![]() |
41. | Miyamoto, S., H. Teramoto, J.S. Gutkind, and K.M. Yamada. 1996. Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. J. Cell Biol. 135: 1633-1642 [Abstract]. |
42. |
Myers, M.G. Jr.,
T.C. Grammer,
L.M. Wang,
X.J. Sun,
J.H. Pierce,
J. Blenis, and
M.F. White.
1994.
Insulin receptor substrate-1 mediates phosphatidylinositol 3'-kinase and p70S6k signaling during insulin, insulin-like growth
factor-1, and interleukin-4 stimulation.
J. Biol. Chem.
269:
28783-28789
|
43. |
Neuenschwander, S.,
A. Schwartz,
T.L. Wood,
C.T. Roberts,
L. Henninghausen, and
D. Leroith.
1996.
Involution of the lactating mammary gland is
inhibited by the Igf system in a transgenic mouse model.
J. Clin. Invest.
97:
2225-2232
|
44. |
Pap, M., and
G.M. Cooper.
1998.
Role of glycogen synthase kinase-3 in the
phosphatidylinositol 3-kinase/Akt cell survival pathway.
J. Biol. Chem.
273:
19929-19932
|
45. |
Parrizas, M.,
A.R. Saltiel, and
D. LeRoith.
1997.
Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways.
J. Biol. Chem.
272:
154-161
|
46. |
Pawson, T., and
J.D. Scott.
1997.
Signaling through scaffold, anchoring, and
adaptor proteins.
Science.
278:
2075-2080
|
47. | Plopper, G.E., H.P. McNamee, L.E. Dike, K. Bojanowski, and D.E. Ingber. 1995. Convergence of integrin and growth-factor receptor signaling pathways within the focal adhesion complex. Mol. Biol. Cell. 6: 1349-1365 [Abstract]. |
48. | Pullan, S., and C.H. Streuli. 1996. The mammary gland epithelial cell. In Epithelial Cell Culture. A. Harris, editor. Cambridge University Press. 97-121. |
49. |
Pullan, S.,
J. Wilson,
A. Metcalfe,
G.M. Edwards,
N. Goberdhan,
J. Tilly,
J.A. Hickman,
C. Dive, and
C.H. Streuli.
1996.
Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium.
J. Cell Sci.
109:
631-642
|
50. |
Renshaw, M.W.,
X.D. Ren, and
M.A. Schwartz.
1997.
Growth factor activation
of MAP kinase requires cell adhesion.
EMBO (Eur. Mol. Biol. Organ.) J.
16:
5592-5599
|
51. |
Rodriguez-Tarduchy, G.,
M.K. Collins,
I. Garcia, and
A. Lopez-Rivas.
1992.
Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic
cells.
J. Immunol.
149:
535-540
|
52. | Ruan, W.F., V. Catanese, R. Wieczorek, M. Feldman, and D.L. Kleinberg. 1995. Estradiol enhances the stimulatory effect of insulin-like growth factor-I (Igf-I) on mammary development and growth hormone-induced Igf-I messenger ribonucleic acid. Endocrinology. 136: 1296-1302 [Abstract]. |
53. | Runswick, S.K., D.R. Garrod, and C.H. Streuli. 1996. The differential expression of desmocollin isoforms in mammary epithelia. Biochem. Soc. Trans. 24: S346 . |
54. |
Scatena, M.,
M. Almeida,
M.L. Chaisson,
N. Fausto,
R.F. Nicosia, and
C.M. Giachelli.
1998.
NF-kappaB mediates alphavbeta3 integrin-induced endothelial
cell survival.
J. Cell Biol.
141:
1083-1093
|
55. |
Scheid, M.P., and
V. Duronio.
1998.
Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: involvement of MEK upstream of Bad phosphorylation.
Proc. Natl. Acad. Sci. USA.
95:
7439-7444
|
56. |
Schneller, M.,
K. Vuori, and
E. Ruoslahti.
1997.
Alpha v beta 3 integrin associates with activated insulin and PDGF beta receptors and potentiates the biological activity of PDGF.
EMBO (Eur. Mol. Biol. Organ.) J.
16:
5600-5607
|
57. | Simons, K., and E. Ikonen. 1997. Functional rafts in cell membranes. Nature. 387: 569-572 |
58. | Strange, R., F. Li, S. Saurer, A. Burkhardt, and R.R. Friis. 1992. Apoptotic cell death and tissue remodeling during mouse mammary gland involution. Development. 115: 49-58 [Abstract]. |
59. | Streuli, C.H. 1995. Basement membrane in the control of mammary gland function. In Intercellular Signalling in the Mammary Gland. C.J. Wilde, M. Peaker, and C.H. Knight, editors. Plenum Press, New York. 141-151. |
60. |
Streuli, C.H.,
N. Bailey, and
M.J. Bissell.
1991.
Control of mammary epithelial
differentiation![]() |
61. |
Streuli, C.H.,
G.M. Edwards,
M. Delcommenne,
C.B.A. Whitelaw,
T.G. Burdon,
C. Schindler, and
C.J. Watson.
1995.
Stat5 as a target for regulation by
extracellular matrix.
J. Biol. Chem.
270:
21639-21644
|
62. | Streuli, C.H., C. Schmidhauser, N. Bailey, P. Yurchenco, A.P. Skubitz, C. Roskelley, and M.J. Bissell. 1995. Laminin mediates tissue-specific gene expression in mammary epithelia. J. Cell Biol. 129: 591-603 [Abstract]. |
63. |
Sun, X.J.,
M. Miralpeix,
M.G. Myers Jr.,
E.M. Glasheen,
J.M. Backer,
C.R. Kahn, and
M.F. White.
1992.
Expression and function of IRS-1 in insulin signal transmission.
J. Biol. Chem.
267:
22662-22672
|
64. | Talhouk, R.S., M.J. Bissell, and Z. Werb. 1992. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J. Cell Biol. 118: 1271-1282 [Abstract]. |
65. | Taub, M., Y. Wang, T.M. Szczesny, and H.K. Kleinman. 1990. Epidermal growth factor or transforming growth factor-alpha is required for kidney tubulogenesis in matrigel cultures in serum-free medium. Proc. Natl. Acad. Sci. USA. 87: 4002-4006 [Abstract]. |
66. |
Tonner, E.,
M.C. Barber,
M.T. Travers,
A. Logan, and
D.J. Flint.
1997.
Hormonal control of insulin-like growth factor binding protein-5 production in
the involuting mammary gland of the rat.
Endocrinology.
138:
5101-5107
|
67. | Ui, M., T. Okada, K. Hazeki, and O. Hazeki. 1995. Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. Trends Biochem Sci. 20: 303-307 |
68. | Vachon, P.H., F. Loechel, H. Xu, U.M. Wewer, and E. Engvall. 1996. Merosin and laminin in myogenesis; specific requirement for merosin in myotube stability and survival. J. Cell Biol. 134: 1483-1497 [Abstract]. |
69. |
Vachon, P.H.,
H. Xu,
L. Liu,
F. Loechel,
Y. Hayashi,
K. Arahata,
J.C. Reed,
U.M. Wewer, and
E. Engvall.
1997.
Integrins (![]() ![]() |
70. |
Vlahos, C.J.,
W.F. Matter,
K.Y. Hui, and
R.F. Brown.
1994.
A specific inhibitor
of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).
J. Biol. Chem.
269:
5241-5248
|
71. | Vuori, K., and E. Ruoslahti. 1994. Association of insulin receptor substrate-1 with integrins. Science. 266: 1576-1578 |
72. | Wary, K.K., F. Mainiero, S.J. Isakoff, E.E. Marcantonio, and F.G. Giancotti. 1996. The adapter protein Shc couples a class of integrins to the control of cell-cycle progression. Cell. 87: 733-743 |
73. | Wewer, U.M., L.M. Shaw, R. Albrechtsen, and A.M. Mercurio. 1997. The integrin alpha 6 beta 1 promotes the survival of metastatic human breast carcinoma cells in mice. Am. J. Pathol. 151: 1191-1198 [Abstract]. |
74. | Yao, R., and G.M. Cooper. 1995. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science. 267: 2003-2006 |
75. | Yee, D., S. Paik, G.S. Lebovic, R.R. Marcus, R.E. Favoni, K.J. Cullen, M.E. Lippman, and N. Rosen. 1989. Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. Mol. Endocrinol. 3: 509-517 [Abstract]. |
76. |
Zhang, Z.H.,
K. Vuori,
J.C. Reed, and
E. Ruoslahti.
1995.
The alpha-5-beta-1
integrin supports survival of cells on fibronectin and up-regulates bcl-2 expression.
Proc. Natl. Acad. Sci. USA.
92:
6161-6165
|
77. | Zhu, X.Y., M. Ohtsubo, R.M. Bohmer, J.M. Roberts, and R.K. Assoian. 1996. Adhesion-dependent cell-cycle progression linked to the expression of cyclin D1, activation of cyclin E-Cdk2, and phosphorylation of the retinoblastoma protein. J. Cell Biol. 133: 391-403 [Abstract]. |